Dexamethasone underused for adults hospitalized with COVID-19

Dexamethasone underused for adults hospitalized with COVID-19

(HealthDay)—For adults hospitalized with COVID-19, dexamethasone and remdesivir use increased over time, although dexamethasone is still somewhat underused, according to a study published online Aug. 17 in the Annals of Internal Medicine.

Hemalkumar B. Mehta, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues characterized the use of hydroxychloroquine, remdesivir, and dexamethasone in a conducted at 43 U.S. health systems involving 137,870 adults hospitalized with COVID-19 between Feb. 1, 2020, and Feb. 28, 2021.

The researchers found that during the study period, 6.3, 21.2, and 39.1 percent of patients received hydroxychloroquine, remdesivir, and dexamethasone, respectively. About 78 to 84 percent of people who have had invasive ventilation have received dexamethasone or other glucocorticoids in the following the release of the results from the Randomised Evaluation of COVID-19 Therapy trial in mid-June 2020. Hydroxychloroquine use increased during March 2020, peaking at 42 percent, then started decreasing by April 2020. In contrast, during the study period, remdesivir and dexamethasone use increased gradually. There was in dexamethasone and remdesivir use across (intraclass correlation coefficient, 14.2 and 84.6 percent, respectively).

"Mehta and colleagues clearly showed how rapidly clinicians can navigate a cacophony of data and incorporate important and meaningful results of clinical research into practice during an infectious disease pandemic," write the authors of an accompanying editorial.


Explore further

Monthly COVID-19 hospitalization rates peaked in December 2020

More information: Abstract/Full Text
Editorial
Journal information: Annals of Internal Medicine

Copyright © 2021 HealthDay. All rights reserved.

Citation: Dexamethasone underused for adults hospitalized with COVID-19 (2021, August 17) retrieved 8 December 2021 from https://medicalxpress.com/news/2021-08-dexamethasone-underused-adults-hospitalized-covid-.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
34 shares

Feedback to editors